$EXEL News Article - Exelixis and Ipsen Announce P
Post# of 73
(Total Views: 197)
Posted On: 08/21/2023 12:35:51 PM
$EXEL News Article - Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer https://marketwirenews.com/news-releases/exel...20896.html
(0)
(0)Exelixis Inc. (EXEL) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼